We previously reported the application of layer-by-layer fabrication of synthetic microparticles (LbL-MP) to generate a novel pre-erythrocytic malaria vaccine presenting subunit epitopes of the Plasmodium CS protein [14]. The gene discussed is CS; the disease is malaria.